65 related articles for article (PubMed ID: 1320300)
1. Partial characterization of an autoantibody recognizing the secondary binding site(s) of thrombin in a patient with recurrent spontaneous arterial thrombosis.
Costa JM; Fiessinger JN; Capron L; Aiach M
Thromb Haemost; 1992 Feb; 67(2):193-9. PubMed ID: 1320300
[TBL] [Abstract][Full Text] [Related]
2. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
Thompson EA; Salem HH
Thromb Haemost; 1987 Oct; 58(3):806-10. PubMed ID: 2829375
[TBL] [Abstract][Full Text] [Related]
3. An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.
Sié P; Bezeaud A; Dupouy D; Archipoff G; Freyssinet JM; Dugoujon JM; Serre G; Guillin MC; Boneu B
J Clin Invest; 1991 Jul; 88(1):290-6. PubMed ID: 1711542
[TBL] [Abstract][Full Text] [Related]
4. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
Schumacher WA; Steinbacher TE; Heran CL; Seiler SM; Michel IM; Ogletree ML
J Pharmacol Exp Ther; 1993 Dec; 267(3):1237-42. PubMed ID: 8263785
[TBL] [Abstract][Full Text] [Related]
5. Energetics of thrombin-thrombomodulin interaction.
Vindigni A; White CE; Komives EA; Di Cera E
Biochemistry; 1997 Jun; 36(22):6674-81. PubMed ID: 9184147
[TBL] [Abstract][Full Text] [Related]
6. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
7. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
[TBL] [Abstract][Full Text] [Related]
8. Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis.
Toulon P; Vitoux JF; Fiessinger JN; Sicard D; Aiach M
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):435-9. PubMed ID: 1718466
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
10. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
[TBL] [Abstract][Full Text] [Related]
11. [Thrombomodulin: a new proteoglycan. Structure-function relation].
Bourin MC
Ann Biol Clin (Paris); 1991; 49(4):199-207. PubMed ID: 1656816
[TBL] [Abstract][Full Text] [Related]
12. Protein C.
Esmon CT
Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
[TBL] [Abstract][Full Text] [Related]
13. Thrombin specificity.
Guillin MC; Bezeaud A; Bouton MC; Jandrot-Perrus M
Thromb Haemost; 1995 Jul; 74(1):129-33. PubMed ID: 8578445
[TBL] [Abstract][Full Text] [Related]
14. The effect of bovine thrombomodulin on the specificity of bovine thrombin.
Jakubowski HV; Kline MD; Owen WG
J Biol Chem; 1986 Mar; 261(8):3876-82. PubMed ID: 3005304
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of an acquired antithrombin antibody.
Lawson JH; Pennell BJ; Olson JD; Mann KG
Blood; 1990 Dec; 76(11):2249-57. PubMed ID: 2257299
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function.
Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK
Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594
[TBL] [Abstract][Full Text] [Related]
17. [Autoantibodies to heparin polysaccharides bind to vascular endothelial cells].
Shibata S
Rinsho Byori; 1998 Dec; 46(12):1205-9. PubMed ID: 9916505
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
Bohner J; von Pape KW; Blaurock M
Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
[TBL] [Abstract][Full Text] [Related]
19. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
Rezaie AR
Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
Tripodi A; Krachmalnicoff A; Mannucci PM
Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]